Additional information
| Trade Name | HERCLON |
|---|---|
| Generic Name | Trastuzumab |
| Manufacturer | Roche Products India Pvt Ltd |
| Drug Type | Oncology |
| Indication | Breast Cancer |
| Doasage Form | Injectible |
| Packaging | 1 x 20ml /440mg |
HERCLON (Trastuzumab)-440mg
HERCLON (Trastuzumab) is a targeted (biological) therapy works by targeting the HER2/neu receptor on cancer cells. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).
Trastuzumab is used to treat;
- Metastatic breast cancer
- HER2-positive early breast cancer following surgery, sequentially or concurrently with chemotherapy and, if applicable, radiotherapy
- Advanced gastric (stomach) cancer
